|
1
|
Barbosa G, de Sá L, Rocha D and Arbex A:
Polycystic ovary syndrome (PCOS) and infertility. Open J Endocr
Metab Dis. 6:58–65. 2016.
|
|
2
|
Lentscher JA and Decherney AH: Clinical
presentation and diagnosis of polycystic ovarian syndrome. Clin
Obstet Gynecol. 64:3–11. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ma X, Li X, Ma L, Chen Y and He S: Soy
isoflavones alleviate polycystic ovary syndrome in rats by
regulating NF-κB signaling pathway. Bioengineered. 12:7204–7212.
2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Harris HR, Titus LJ, Cramer DW and Terry
KL: Long and irregular menstrual cycles, polycystic ovary syndrome,
and ovarian cancer risk in a population-based case-control study.
Int J Cancer. 140:285–291. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ashraf S, Nabi M, Rasool SUA, Rashid F and
Amin S: Hyperandrogenism in polycystic ovarian syndrome and role of
CYP gene variants: A review. Egypt J Med Hum Genet. 20(25)2019.
|
|
6
|
Smet ME and McLennan A: Rotterdam
criteria, the end. Australas J Ultrasound Med. 21:59–60.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Reid SP, Kao CN, Pasch L, Shinkai K,
Cedars MI and Huddleston HG: Ovarian morphology is associated with
insulin resistance in women with polycystic ovary syndrome: A cross
sectional study. Fertil Res Pract. 3(8)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rodriguez Paris V and Bertoldo MJ: The
mechanism of androgen actions in PCOS etiology. Med Sci (Basel).
7(89)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kamboj A, Verma D, Sharma D, Pant K, Pant
B and Kumar V: A molecular docking study towards finding herbal
treatment against polycystic ovary syndrome (PCOS). Int J Recent
Technol Eng. 8:38–41. 2019.
|
|
10
|
Gayathri K, Supriya V and Palaniappan N:
Nutritional composition and sensory evaluation of
phytoestrogen-rich supplement for women with PCOS. Int J Nutr
Pharmacol Neurol Dis. 11:303–308. 2021.
|
|
11
|
Shehab NG, Anbar HS, Alrouby NM,
Abouelalamin A, Lutfi L, Allo IT and Elayoty SM: New alternative
herbal remedies for treatment of letrozole-induced polycystic ovary
syndrome in rats. J Appl Pharm Sci. 13:163–179. 2023.
|
|
12
|
Moini Jazani A, Nasimi Doost Azgomi H,
Nasimi Doost Azgomi A and Nasimi Doost Azgomi R: A comprehensive
review of clinical studies with herbal medicine on polycystic ovary
syndrome (PCOS). DARU. 27:863–877. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Jang HH, Lee YM, Choe JS and Kwon O:
Validation of soy isoflavone intake and its health effects: A
review of the development of exposure biomarkers. Nutr Res Pract.
15:1–11. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Manzar N, Khan AS, Fatima N, Nisa M, Ahmad
MH, Afzal MI, Saeed HFU, Imran M, Anjum FM and Arshad MS: Exploring
the prophylactic role of soy isoflavones against polycystic ovarian
syndrome. Food Sci Nutr. 9:4738–4744. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gómez-Zorita S, González-Arceo M,
Fernández-Quintela A, Eseberri I, Trepiana J and Portillo MP:
Scientific evidence supporting the beneficial effects of
isoflavones on human health. Nutrients. 12(3853)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Křížová L, Dadáková K, Kašparovská J and
Kašparovský T: Isoflavones. Molecules. 24(1076)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Leonard LM, Choi MS and Cross TL:
Maximizing the estrogenic potential of soy isoflavones through the
gut microbiome: Implication for cardiometabolic health in
postmenopausal women. Nutrients. 14(553)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Desmawati D and Sulastri D: Phytoestrogens
and their health effect. Open Access Maced J Med Sci. 7:495–499.
2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Xu XL, Deng SL, Lian ZX and Yu K: Estrogen
receptors in polycystic ovary syndrome. Cells.
10(459)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Rajan RK, Kumar MSS and Balaji B: Soy
isoflavones exert beneficial effects on letrozole-induced rat
polycystic ovary syndrome (PCOS) model through anti-androgenic
mechanism. Pharm Biol. 55:242–251. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Abbasian Z, Barmak MJ, Barazesh F,
Ghavamizadeh M and Mirzaei A: Therapeutic efficacy of Trifolium
pratense L. on letrozole induced polycystic ovary syndrome in rats.
Plant Sci Today. 7:501–507. 2020.
|
|
22
|
Xu J, Dun J, Yang J, Zhang J, Lin Q, Huang
M, Ji F, Huang L, You X and Lin Y: Letrozole rat model mimics human
polycystic ovarian syndrome and changes in insulin signal pathways.
Med Sci Monit. 26(e923073)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yang AM, Cui N, Sun YF and Hao GM:
Letrozole for female infertility. Front Endocrinol (Lausanne).
12(676133)2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Rajaei S, Alihemmati A and Abedelahi A:
Antioxidant effect of genistein on ovarian tissue morphology,
oxidant and antioxidant activity in rats with induced polycystic
ovary syndrome. Int J Reprod Biomed. 17:11–22. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Alivandi Farkhad S and Khazali H:
Therapeutic effects of isoflavone-aglycone fraction from soybean
(Glycine max L. Merrill) in rats with estradiol valerate-induced
polycystic ovary syndrome as an inflammatory state. Gynecol
Endocrinol. 35:1078–1083. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ramadoss M, Vijayaraman M and Subbiah AJ:
Estradiol valerate dose determination for PCOS induction. Int J
Pharm Biol Sci. 9:1131–1136. 2019.
|
|
27
|
Rotterdam ESHRE/ASRM-Sponsored PCOS
consensus workshop group. Revised 2003 consensus on diagnostic
criteria and long-term health risks related to polycystic ovary
syndrome (PCOS). Hum Reprod. 19:41–47. 2004.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li W, Hu H, Zou G, Ma Z, Liu J and Li F:
Therapeutic effects of puerarin on polycystic ovary syndrome: A
randomized trial in Chinese women. Medicine (Baltimore).
100(e26049)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Blouin K, Boivin A and Tchernof A:
Androgens and body fat distribution. J Steroid Biochem Mol Biol.
108:272–280. 2008.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Homburg R: Androgen circle of polycystic
ovary syndrome. Hum Reprod. 24:1548–1555. 2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Dumesic DA, Abbott DH, Sanchita S and
Chazenbalk GD: Endocrine-metabolic dysfunction in polycystic ovary
syndrome: An evolutionary perspective. Curr Opin Endocr Metab Res.
12:41–48. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Rasmussen MK, Ekstrand B and Zamaratskaia
G: Regulation of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase: A
review. Int J Mol Sci. 14:17926–17942. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kater CE, Giorgi RB and Costa-Barbosa FA:
Classic and current concepts in adrenal steroidogenesis: A
reappraisal. Arch Endocrinol Metab. 66:77–87. 2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Murri M, Luque-Ramı´rez M, Insenser M,
Ojeda-Ojeda M and Escobar-Morreale HF: Circulating markers of
oxidative stress and polycystic ovary syndrome (PCOS): A systematic
review and meta-analysis. Hum Reprod Update. 19:268–288.
2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Karabulut AB, Cakmak M, Kiran RT and Sahin
I: Oxidative stress status, metabolic profile and cardiovascular
risk factors in patients with polycystic ovary syndrome. Med
Science. 1:27–34. 2012.
|
|
36
|
Diamanti-Kandarakis E, Piperi C,
Kalofoutis A and Creatsas G: Increased levels of serum advanced
glycation end-products in women with polycystic ovary syndrome.
Clin Endocrinol (Oxf). 62:37–43. 2005.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Isık H, Aynıoglu O, Tımur H, Sahbaz A,
Harma M, Can M, Guven B, Alptekin H and Kokturk F: Is Xanthine
oxidase activity in polycystic ovary syndrome associated with
inflammatory and cardiovascular risk factors? J Reprod Immunol.
116:98–103. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Mohammadi M: Oxidative stress and
polycystic ovary syndrome: A brief review. Int J Prev Med.
10(86)2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Enechukwu CI, Onuegbu AJ, Olisekodiaka MJ,
Eleje GU, Ikechebelu JI, Ugboaja JO, Amah UK, Okwara JE and Igwegbe
AO: Oxidative stress markers and lipid profiles of patients with
polycystic ovary syndrome in a Nigerian tertiary hospital. Obstet
Gynecol Sci. 62:335–343. 2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Fathi FH: Biomarkers of oxidative stress
in polycystic ovary disorder. Ann Coll Med Mosul. 41:112–116.
2019.
|
|
41
|
Jamilian M and Asemi Z: The effects of soy
isoflavones on metabolic status of patients with polycystic ovary
syndrome. J Clin Endocrinol Metab. 101:3386–3394. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Karamali M, Kashanian M, Alaeinasab S and
Asemi Z: The effect of dietary soy intake on weight loss, glycaemic
control, lipid profiles and biomarkers of inflammation and
oxidative stress in women with polycystic ovary syndrome: A
randomised clinical trial. J Hum Nutr Diet. 31:533–543.
2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Jamilian M and Sahebkashaf R: Metabolic
response to soy supplementation in women with polycystic ovary
syndrome. J Arak Uni Med Sci. 20:14–23. 2017.
|
|
44
|
Herman R, Sever MJ, Janež A and Vita D:
Interplay between oxidative stress and chronic inflammation in
PCOS: the role of genetic variability in PCOS risk and treatment
responses. IntechOpen. Ch 8:2020.
|
|
45
|
Amanat S, Ashkar F, Eftekhari MH, Tanideh
N, Doaei S, Gholamalizadeh M, Koohpeyma F and Mokhtari M: The
effect of genistein on insulin resistance, inflammatory factors,
lipid profile, and histopathologic indices in rats with polycystic
ovary syndrome. Clin Exp Reprod Med. 48:236–244. 2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yu J, Bi X, Yu B and Chen D: Isoflavones:
Anti-inflammatory benefit and possible caveats. Nutrients.
8(361)2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Khani B, Mehrabian F, Khalesi E and
Eshraghid A: Effect of soy phytoestrogen on metabolic and hormonal
disturbance of women with polycystic ovary syndrome. J Res Med Sci.
16:297–302. 2011.PubMed/NCBI
|
|
48
|
Saadia Z: Follicle stimulating hormone
(LH: FSH) ratio in polycystic ovary syndrome (PCOS)-obese vs.
non-obese women. Med Arch. 74:289–293. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Madnani N, Khan K, Chauhan P and Parmar G:
Polycystic ovarian syndrome. Indian J Dermatol Venereol Leprol.
79:310–321. 2013.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Ekambaram G, Sampath Kumar SK and Joseph
LD: Comparative study on the estimation of estrous cycle in mice by
visual and vaginal lavage method. J Clin Diagnostic Res.
11:AC05–AC07. 2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Ajayi AF and Akhigbe RE: Staging of the
estrous cycle and induction of estrus in experimental rodents: An
update. Fertil Res Pract. 6(5)2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Nallathambi A and Bhargavan R: Regulation
of estrous cycle by Cynodon dactylon in letrozole induced
polycystic ovarian syndrome in Wistars albino rats. Anat Cell Biol.
52:511–517. 2019.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Shilpa N, Itagi V and Rani R: A study of
hemoglobin concentration in different phases of menstrual cycle.
Int J Physiol. 6:90–94. 2018.
|
|
54
|
Jahan S, Abid A, Khalid S, Afsar T,
Qurat-Ul-Ain Shaheen G, Almajwal A and Razak S: Therapeutic
potentials of quercetin in management of polycystic ovarian
syndrome using letrozole induced rat model: A histological and a
biochemical study. J Ovarian Res. 11(26)2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Teixeira CP, Florencio-Silva R, Sasso GRS,
Carbonel AAF, Simões RS and Simões MJ: Soy isoflavones protect
against oxidative stress and diminish apoptosis in ovary of
middle-aged female rats. Gynecol Endocrinol. 35:586–590.
2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Khezri S, Alihemmati A and Abedelahi A:
Genistein blunted detrimental effects of polycystic ovary syndrome
on the ovarian tissue of rats by improving follicular development
and gonadotropin secretion. JBRA Assist Reprod. 26:379–386.
2022.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Ali SE, El Badawy SA, Elmosalamy SH, Emam
SR, Azouz AA, Galal MK, Abd-Elsalam RM, Issa MY and Hassan BB:
Novel promising reproductive and metabolic effects of Cicer
arietinum L. extract on letrozole induced polycystic ovary
syndrome in rat model. J Ethnopharmacol. 278(114318)2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Geethika L and Okada S: Investigating the
effect of soy isoflavones on improving polycystic ovary syndrome
hallmarks liyanage. Soy Protein Research. 21:90–94. 2018.
|
